Webinar | August 9, 2017

What’s New on Section 101 Jurisprudence

  • post-grant-review1
  • life-sciences-research
  • patent-litigation
Share

In this webinar, the panel, including Brooks Kuhsman Shareholder David Randall, discussed updates on patent eligible subject matter since the Alice Bank, Enfish, Mayo Collaborative, and Sequenom v. Ariosa line of cases. They covered case law from federal courts, decisions from the PTAB, results of the USPTO’s roundtables last year on Section 101, as well as recent recommendations from trade associations such as IPO and AIPLA on proposals for legislation change. The panel also discussed the effect of current Section 101 jurisprudence on the technology, software, and biotechnology/biologics industries, and whether the laws as applied in the U.S. are consistent with our obligations under certain international treaties.

 

Related Webinars

Brooks Kushman
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.